HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul A Clarke Selected Research

PI 620

7/2009Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul A Clarke Research Topics

Disease

43Neoplasms (Cancer)
11/2020 - 10/2003
7Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 10/2003
4Glioblastoma (Glioblastoma Multiforme)
07/2017 - 07/2009
3Melanoma (Melanoma, Malignant)
01/2018 - 03/2007
3Ovarian Neoplasms (Ovarian Cancer)
07/2012 - 04/2007
2Neuroblastoma
11/2020 - 01/2016
2Breast Neoplasms (Breast Cancer)
01/2020 - 05/2017
2Colonic Neoplasms (Colon Cancer)
01/2018 - 05/2012
2Carcinogenesis
12/2016 - 09/2008
2Carcinoma (Carcinomatosis)
11/2013 - 07/2010
2Glioma (Gliomas)
02/2009 - 06/2007
1Leukemia
01/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2020
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2020
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2020
1Chordoma
01/2019
1Cardiovascular Diseases (Cardiovascular Disease)
12/2015
1Ovarian Epithelial Carcinoma
01/2015
1Urinary Bladder Neoplasms (Bladder Cancer)
10/2013
1Esophageal Neoplasms (Esophageal Cancer)
03/2011
1Pathologic Processes
03/2010

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
01/2020 - 10/2003
8Biomarkers (Surrogate Marker)IBA
01/2020 - 06/2007
8Phosphotransferases (Kinase)IBA
01/2019 - 05/2013
8Pharmaceutical PreparationsIBA
01/2018 - 06/2007
8PI103IBA
01/2017 - 06/2007
5Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2020 - 05/2017
5Protein Isoforms (Isoforms)IBA
05/2017 - 09/2008
5tanespimycin (17AAG)IBA
05/2014 - 10/2003
4Temozolomide (Temodar)FDA LinkGeneric
11/2020 - 02/2009
4Biological ProductsIBA
01/2020 - 10/2003
4Phosphorylcholine (Phosphocholine)IBA
07/2017 - 07/2010
42- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA
01/2015 - 09/2008
4Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
08/2013 - 09/2008
3Lactic Acid (Lactate)FDA LinkGeneric
07/2017 - 01/2014
3MTOR InhibitorsIBA
07/2017 - 01/2016
3Choline (Choline Chloride)IBA
01/2017 - 07/2010
3Heat-Shock Proteins (Heat-Shock Protein)IBA
05/2014 - 04/2007
3Phosphatidylinositols (Phosphatidylinositol)IBA
01/2014 - 07/2010
2CYC065IBA
11/2020 - 01/2020
2Transcription Factors (Transcription Factor)IBA
11/2020 - 01/2019
2Oncogene Proteins (Oncogene Protein)IBA
01/2020 - 01/2016
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019 - 01/2018
2Drug CombinationsIBA
01/2019 - 05/2012
2Mediator ComplexIBA
02/2016 - 12/2015
2Protein Kinases (Protein Kinase)IBA
05/2014 - 09/2008
2DNA (Deoxyribonucleic Acid)IBA
01/2014 - 05/2012
2Protons (Proton)IBA
01/2014 - 07/2010
2Phosphorus (Red Phosphorus)IBA
01/2014 - 07/2010
2Molecular Chaperones (Chaperone, Molecular)IBA
11/2013 - 09/2008
2LigandsIBA
10/2013 - 08/2013
2RNA (Ribonucleic Acid)IBA
03/2011 - 10/2003
2Cytotoxins (Cytolysins)IBA
06/2009 - 02/2009
2Proteasome Endopeptidase Complex (Proteasome)IBA
02/2009 - 09/2008
1Adrenergic Agents (Adrenergic Drugs)IBA
11/2020
1DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
01/2020
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2020
1venetoclaxIBA
01/2020
1RNA Polymerase II (RNA Polymerase B)IBA
01/2020
1Serine (L-Serine)FDA Link
01/2020
1AphidicolinIBA
01/2020
1Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA
01/2020
1SRA737IBA
01/2020
1Brachyury protein (Brachyury)IBA
01/2019
1Antineoplastic Agents (Antineoplastics)IBA
01/2018
1purineIBA
01/2018
1Complement System Proteins (Complement)IBA
01/2018
1RoscovitineIBA
01/2018
1Caspase 3 (Caspase-3)IBA
07/2017
1dactolisibIBA
07/2017
1Messenger RNA (mRNA)IBA
07/2017
1palbociclibIBA
05/2017
1Cyclin-Dependent Kinase 8IBA
02/2016
1N-Myc Proto-Oncogene ProteinIBA
01/2016
1CCT251545IBA
12/2015
1idelalisibIBA
08/2015
1Ribosomal Proteins (Ribosomal Protein)IBA
01/2015
1PlatinumIBA
01/2015
1Ligases (Synthetase)IBA
05/2014
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
05/2014
1Cullin Proteins (Cullins)IBA
05/2014
1Small Interfering RNA (siRNA)IBA
05/2014
1benzimidazoleIBA
10/2013
1OxadiazolesIBA
10/2013
1trans-sodium crocetinate (crocetin)IBA
10/2013
1Ribosomal Protein S6 Kinases (S6 Kinase)IBA
10/2013
1Adenosine Triphosphate (ATP)IBA
05/2013
1Therapeutic UsesIBA
05/2013
1Death Domain ReceptorsIBA
05/2012
1Choline KinaseIBA
05/2012
1ProteomeIBA
04/2012
1Complementary DNA (cDNA)IBA
03/2011
1EnzymesIBA
03/2010

Therapy/Procedure

13Therapeutics
11/2020 - 10/2003
3Drug Therapy (Chemotherapy)
07/2012 - 03/2011
2Radiotherapy
07/2017 - 01/2014
1Oral Administration
10/2016
1Precision Medicine
08/2015